223 related articles for article (PubMed ID: 22911550)
41. Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia.
Rasi S; Bruscaggin A; Rinaldi A; Cresta S; Fangazio M; De Paoli L; Monti S; Gargiulo E; Kwee I; Foà R; Bertoni F; Gaidano G; Rossi D
Leuk Res; 2011 Oct; 35(10):1419-22. PubMed ID: 21663967
[TBL] [Abstract][Full Text] [Related]
42. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.
Rassenti LZ; Kipps TJ
J Exp Med; 1993 Apr; 177(4):1039-46. PubMed ID: 7681468
[TBL] [Abstract][Full Text] [Related]
43. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia.
Saddler C; Ouillette P; Kujawski L; Shangary S; Talpaz M; Kaminski M; Erba H; Shedden K; Wang S; Malek SN
Blood; 2008 Feb; 111(3):1584-93. PubMed ID: 17971485
[TBL] [Abstract][Full Text] [Related]
45. The genomic landscape of chronic lymphocytic leukaemia: biological and clinical implications.
Strefford JC
Br J Haematol; 2015 Apr; 169(1):14-31. PubMed ID: 25496136
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
[TBL] [Abstract][Full Text] [Related]
47. [Pathogenesis of chronic lymphocytic leukemia].
Fukuda T
Rinsho Ketsueki; 2015 Mar; 56(3):261-8. PubMed ID: 25876778
[TBL] [Abstract][Full Text] [Related]
48. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.
Schuh A; Becq J; Humphray S; Alexa A; Burns A; Clifford R; Feller SM; Grocock R; Henderson S; Khrebtukova I; Kingsbury Z; Luo S; McBride D; Murray L; Menju T; Timbs A; Ross M; Taylor J; Bentley D
Blood; 2012 Nov; 120(20):4191-6. PubMed ID: 22915640
[TBL] [Abstract][Full Text] [Related]
49. Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation.
Klinger M; Zheng J; Elenitoba-Johnson KS; Perkins SL; Faham M; Bahler DW
Leukemia; 2016 May; 30(5):1055-61. PubMed ID: 26686246
[TBL] [Abstract][Full Text] [Related]
50. The
Perez-Chacon G; Zapata JM
Front Immunol; 2021; 12():627602. PubMed ID: 33912159
[TBL] [Abstract][Full Text] [Related]
51. Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV
Burns A; Alsolami R; Becq J; Stamatopoulos B; Timbs A; Bruce D; Robbe P; Vavoulis D; Clifford R; Cabes M; Dreau H; Taylor J; Knight SJL; Mansson R; Bentley D; Beekman R; Martín-Subero JI; Campo E; Houlston RS; Ridout KE; Schuh A
Leukemia; 2018 Feb; 32(2):332-342. PubMed ID: 28584254
[TBL] [Abstract][Full Text] [Related]
52. TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemia.
Malcikova J; Pavlova S; Kozubik KS; Pospisilova S
Hum Mutat; 2014 Jun; 35(6):663-71. PubMed ID: 24415659
[TBL] [Abstract][Full Text] [Related]
53. Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution.
Kasar S; Kim J; Improgo R; Tiao G; Polak P; Haradhvala N; Lawrence MS; Kiezun A; Fernandes SM; Bahl S; Sougnez C; Gabriel S; Lander ES; Kim HT; Getz G; Brown JR
Nat Commun; 2015 Dec; 6():8866. PubMed ID: 26638776
[TBL] [Abstract][Full Text] [Related]
54. Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia.
Chun K; Wenger GD; Chaubey A; Dash DP; Kanagal-Shamanna R; Kantarci S; Kolhe R; Van Dyke DL; Wang L; Wolff DJ; Miron PM
Cancer Genet; 2018 Dec; 228-229():236-250. PubMed ID: 30554732
[TBL] [Abstract][Full Text] [Related]
55. Molecular bases of chronic lymphocytic leukemia in light of new treatments.
Rossi D; Ciardullo C; Spina V; Gaidano G
Immunol Lett; 2013; 155(1-2):51-5. PubMed ID: 24103588
[TBL] [Abstract][Full Text] [Related]
56. Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis.
Defrancesco I; Zibellini S; Boveri E; Frigeni M; Ferretti VV; Rizzo E; Bonometti A; Capuano F; Candido C; Rattotti S; Tenore A; Picone C; Flospergher E; Zerbi C; Bergamini F; Fabbri N; Cristinelli C; Varettoni M; Paulli M; Arcaini L
Hematol Oncol; 2020 Dec; 38(5):689-697. PubMed ID: 32738175
[TBL] [Abstract][Full Text] [Related]
57. Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia.
Wernig-Zorc S; Yadav MP; Kopparapu PK; Bemark M; Kristjansdottir HL; Andersson PO; Kanduri C; Kanduri M
Epigenetics Chromatin; 2019 Jan; 12(1):4. PubMed ID: 30616658
[TBL] [Abstract][Full Text] [Related]
58. New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing.
Doménech E; Gómez-López G; Gzlez-Peña D; López M; Herreros B; Menezes J; Gómez-Lozano N; Carro A; Graña O; Pisano DG; Domínguez O; García-Marco JA; Piris MA; Sánchez-Beato M
PLoS One; 2012; 7(6):e38158. PubMed ID: 22675518
[TBL] [Abstract][Full Text] [Related]
59. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
60. The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia.
Martínez-Trillos A; Pinyol M; Delgado J; Aymerich M; Rozman M; Baumann T; González-Díaz M; Hernández JM; Alcoceba M; Muntañola A; Terol MJ; Navarro B; Giné E; Jares P; Beà S; Navarro A; Colomer D; Nadeu F; Colado E; Payer AR; García-Cerecedo T; Puente XS; López-Otin C; Campo E; López-Guillermo A; Villamor N
Leuk Lymphoma; 2018 Oct; 59(10):2318-2326. PubMed ID: 29115891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
